Brown University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Brown University sits in the top decile of US sponsors by registered trial count (#141 of 15,742 sponsors by registered trial count).
Brown University: 231 sponsored US clinical trials, 34 recruiting.
Brown University sponsors 231 registered US clinical trials on ClinicalTrials.gov, 34 of them currently recruiting, and 156 completed. 6 of these trials are in Phase 3-4 (later-stage) and 89 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Alcohol Drinking, with 8 trials.
Top-decile sponsor footprint
Brown University ranks in the top decile of sponsors by registered trial count (#141 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
156 of 179 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (87.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
231 total, page 4 of 5
Small Monetary Incentives to Promote Exercise (Exercise4Good; EX4G)
NCT03134040
Pragmatic Trial of Video Education in Nursing Homes
NCT02612688
Mindfulness-Based Blood Pressure Reduction (MB-BP) Intervention Development - Stage 1 Single Arm Trial
NCT02702258
Latino/a Adolescents With Suicidal Behavior
NCT02820636
Prospective Evaluation of Family Care Rituals in the ICU
NCT02875912
Developing a Low-Intensity Primary Care Intervention for Anxiety Disorders (AIM-PC)
NCT02579915
Very Low Nicotine Cigarettes in Smokers With Schizophrenia
NCT02019459
Mifepristone for the Prevention of Relapses of Alcohol Drinking
NCT02243709
BrUOG 292: FOLFOX-A For Metastatic Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial
NCT02080221
BrUOG 291: Five Fraction Partial Breast Irradiation Using Non-invasive Image-guided Breast Brachytherapy (NIBB)
NCT01961531
Neoadjuvant Gemcitabine and Fractionated, Weekly Cisplatin For Muscle Invasive Bladder Cancer and Patients Not Candidates For High Dose Cisplatin
NCT02030574
Developing a Low-Intensity Primary Care Intervention for Anxiety Disorders
NCT02266446
Very Low-Nicotine Cigarettes in Smokers With SUD
NCT01989507
Adjunctive Psychotherapy for Perinatal Bipolar Disorder
NCT02402738
Neurophysiologic Maturation Index for Late Preterm Infants
NCT02156817
BrUOG 295: Adjuvant FOLFOX-A For Resected Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial
NCT02022033
Pilot Study of Adjunctive Yoga for Bipolar Depression
NCT02402010
Skills to Enhance Positive Affect in Suicidal Adolescents
NCT02130583
Rectal Cancer Consortium
NCT01835925
Study of Infusion of Blood Cells (Lymphocytes) to Stimulate the Immune System to Fight Leukemia/Lymphoma
NCT01685606
Dismantling Mindfulness: Contributions of Attention vs. Acceptance
NCT01831362
A Phase I/II Evaluation of ADXS11-001, Mitomycin, 5-fluorouracil (5-FU) and IMRT for Anal Cancer
NCT01671488
Cabazitaxel and Radiation For Patients With Prostate Cancer
NCT01650285
Adjuvant Aflibercept for Metastatic Colorectal Cancer
NCT01669720
BrUOG 278: FOLFOX-A For Pancreatic Cancer A Brown University Oncology Research Group Study
NCT01744353
Low Dose Naltrexone for Metastatic Melanoma, Castrate Resistant Prostate Cancer and Renal Cancer
NCT01650350
Coping Long Term With Attempted Suicide - Adolescents
NCT01748760
Intensive Outpatient Services for Teens
NCT01732601
Community-Based Integrated Treatment for Adolescents
NCT01667159
Effects of Topiramate on Adolescent Alcohol Use: Efficacy and Mechanisms
NCT01641445
Acute Effects of Exercise in Smokers With Schizophrenia
NCT01635075
A Novel Pharmacotherapy for Alcoholism and Alcohol Liver Disease
NCT01504295
Quit Smoking With Nicotine Patch and Exercise/Health Education (Females Only)
NCT01522274
Effectiveness of Interpersonal Psychotherapy (IPT) for Men and Women Prisoners With Major Depression
NCT01685294
Doxazosin an a1 Antagonist for Alcohol Dependence
NCT01437046
Assessment of the Effectiveness of Chemotherapy Teaching: BrUOG 258
NCT01827761
Development of Positive Psychotherapy for Smoking Cessation
NCT01451814
HIV/STI Risk Reduction for Incarcerated Women With Interpersonal Violence
NCT01907126
PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation
NCT01402063
The Effect of Rasagiline on Cognition in Parkinson's Disease
NCT01382342
Brief Alcohol Intervention for HIV-Infected Men Who Have Sex With Men (MSM) in a Primary Care Setting
NCT01328743
Brief Interventions in the Emergency Department for Alcohol and HIV/Sexual Risk
NCT01351389
Effects of Ghrelin on Alcohol Cue Reactivity and Craving
NCT01190085
Pharmacy Home Adherence Reporting and Monitoring Outcomes Study
NCT02306122
Teens Coping With Parental Military Deployment
NCT01128777
Individual and Family Motivational Interviews for Substance Using Truant Teens
NCT01170026
Ofatumumab and Bortezomib for Patients With Low-grade B-cell Non-hodgkin Lymphoma That Relapse After Rituximab
NCT01119794
Group Interpersonal Psychotherapy for Treatment of Major Depressive Disorder Following Perinatal Loss
NCT01867749
First-Line FOLFOX-Bevacizumab for Advanced Colorectal Cancer With Wild-Type Ras
NCT01057017
A Study on the Biobehavioral Mechanisms of Baclofen and Alcohol Drinking
NCT01076283
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 32 |
| Phase 2 | 57 |
| Phase 3 | 4 |
| Phase 4 | 2 |
Therapeutic Areas
What is open in the Brown University pipeline
34 recruiting of 231 indexed (15% open); 156 completed (68%).
Phase mix: 6 late (III/IV) vs 89 early (I/II) (early-phase heavy).
Top condition: Alcohol Drinking (8 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Brown University: open-pipeline peers nationwide
Peers matched on 231 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
Brown University sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 231 trials (± recruiting share)
- University Hospitals Cleveland Medical Center · 230 trials · 18% recruiting
- Henry Ford Health System · 234 trials · 18% recruiting
- University of Iowa · 228 trials · 12% recruiting
- Georgetown University · 227 trials · 15% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Amicus Therapeutics · 15% recruiting · 34 trials
- Loma Linda University · 15% recruiting · 237 trials
- University of Rochester · 15% recruiting · 636 trials
- United States Naval Medical Center, San Diego · 15% recruiting · 41 trials
Related
What to do with this Brown University page
231 registered trials is a research-attention snapshot, not an endorsement of Brown University or any single study.
- 34 of Brown University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Alcohol Drinking is the condition Brown University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Alcohol Drinking trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Brown University pipeline card: 231 registered trials from official public datasets.Report a data error.